✦ LIBER ✦

Clinical significance of the expression of epidermal growth factor and its receptor in esophageal cancer

✍ Scribed by Hidenori Mukaida; Masakazu Toi; Toshihiro Hirai; Yoshinori Yamashita; Tetsuya Toge

Publisher: John Wiley and Sons
Year: 1991
Tongue: English
Weight: 659 KB
Volume: 68
Category: Article
ISSN: 0008-543X
DOI: 10.1002/1097-0142(19910701)68:1<142::aid-cncr2820680126>3.0.co;2-x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Prognostic significance of epidermal gro

Prognostic significance of epidermal growth factor receptor in esophageal squamous cell carcinomas

✍ Soji Ozawa; Masakazu Ueda; Nobutoshi Ando; Nobuyoshi Shimizu; Osahiko Abe 📂 Article 📅 1989 🏛 John Wiley and Sons 🌐 English ⚖ 478 KB 👁 2 views

Expression of epidermal growth factor re

Expression of epidermal growth factor receptor in urinary bladder cancer metastases

✍ Peter Bue; Kenneth Wester; Anna Sjöström; Anders Holmberg; Sten Nilsson; Jörgen 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 French ⚖ 518 KB

Bladder cancers frequently exhibit an increased number of epidermal growth factor receptors (EGFR) in comparison to normal urothelium. The EGFR could potentially be a target for toxic conjugates. The aim of our study was to compare the expression of EGFR in metastases with concurrent or primary tumo

Decreased expression of epidermal growth

Decreased expression of epidermal growth factor and its receptor in the malignant transformation of trophoblasts

✍ Cecilia A. Ladines-Llave; Takeshi Maruo; Augusto M. Manalo; Matsuto Mochizuki 📂 Article 📅 1993 🏛 John Wiley and Sons 🌐 English ⚖ 630 KB

Background. Gestational trophoblastic neoplasms comprise the neoplastic spectrum of nonmalignant hydatidiform mole, invasive hydatidiform mole, and truly malignant choriocarcinoma. Increasing evidence indicates that epidermal growth factor (EGF) acts as an enhancer of trophoblast function to produce

Epidermal growth factor receptor express

Epidermal growth factor receptor expression in breast cancer association with biologic phenotype and clinical outcomes

✍ Mothaffar F. Rimawi; Priya B. Shetty; Heidi L. Weiss; Rachel Schiff; C. Kent Osb 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 231 KB 👁 2 views

Differential expression of epidermal gro

Differential expression of epidermal growth factor receptor in human head and neck cancers

✍ Li Dao Ke; Karen Adler-Storthz; Gary L. Clayman; Alfred W. K. Yung; Zhuo Chen 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 165 KB 👁 2 views

## Background: Over-expression of human epidermal growth factor receptor (egfr) is associated with a variety of human malignancies, including head and neck cancer. it has also been studied for its effect on cancer cell responses to chemotherapy. to accurately measure changes in egfr expression that

Heparin-binding epidermal growth factor-

Heparin-binding epidermal growth factor-like growth factor isoforms and epidermal growth factor receptor/ErbB1 expression in bladder cancer and their relation to clinical outcome

✍ Christopher Kramer; Kai Klasmeyer; Hans Bojar; Wolfgang A. Schulz; Rolf Ackerman 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 313 KB 👁 1 views

## Abstract ## BACKGROUND. Cleavage of membrane‐anchored heparin‐binding epidermal growth factor‐like growth factor (proHB‐EGF) yields a soluble HB‐EGF isoform (sHB‐EGF), which is an activating epidermal growth factor receptor (EGFR) ligand and a C‐terminal fragment HB‐EGF‐C acting directly in the